- ISIN
- US45824Q5071
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Apr 25, 2013
Highlights
- Market Cap
- $1.09M
- Enterprise Value
- -$2.79M
- EPS (TTM)
- -$8.36
- Gross Profit (TTM)
- -$34.00K
- EBITDA (TTM)
- -$8.18M
- Year Range
- $0.43 - $15.90
- ROA (TTM)
- -188.73%
- ROE (TTM)
- 966.04%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GCTK Performance Chart
GlucoTrack Inc (GCTK) is down 82.8% since the beginning of the year. At $1 per share, GCTK is trading 95.8% below its 52-week high of $16. Investors who bought $1,000 worth of GCTK shares 5 years ago would now be looking at an investment worth $0.
Loading charts...
Returns By Period
GlucoTrack Inc (GCTK) has returned -82.81% so far this year and -92.24% over the past 12 months. Over the last ten years, GCTK has returned -73.10% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.
GlucoTrack Inc
- 1D
- 0.67%
- 1M
- -9.59%
- YTD
- -82.81%
- 6M
- -88.51%
- 1Y
- -92.24%
- 3Y*
- -93.61%
- 5Y*
- -88.05%
- 10Y*
- -73.10%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
GCTK Monthly Returns History
Based on dividend-adjusted daily data since Apr 25, 2013, GCTK's average daily return is +0.25%, while the average monthly return is -2.67%.
Historically, 35% of months were positive and 65% were negative. The best month was Dec 2018 with a return of +194.1%, while the worst month was Nov 2024 at -85.5%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.
On a daily basis, GCTK closed higher 23% of trading days. The best single day was Dec 17, 2018 with a return of +240.0%, while the worst single day was Nov 13, 2024 at -77.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -50.65% | -18.85% | -58.06% | 31.37% | -22.71% | 0.82% | -82.81% | ||||||
| 2025 | -82.84% | -71.78% | -51.69% | -0.74% | -25.12% | -22.90% | 2.50% | -31.38% | 56.16% | -1.82% | 5.10% | -43.09% | -99.14% |
| 2024 | -19.66% | 42.79% | 10.37% | 61.58% | -13.27% | -13.36% | -40.30% | 116.60% | -7.28% | -30.29% | -85.54% | 53.50% | -71.47% |
| 2023 | -8.51% | -6.59% | -71.78% | 23.53% | -4.60% | -13.88% | -8.37% | -17.77% | 0.96% | -31.28% | 30.27% | 11.28% | -81.45% |
| 2022 | -17.96% | -0.46% | 6.90% | -21.15% | -5.92% | -4.26% | -7.16% | -21.67% | 5.85% | -7.54% | -14.13% | -10.76% | -66.19% |
| 2021 | -7.04% | 3.03% | -16.18% | 22.81% | 0.00% | 17.14% | -2.44% | 17.31% | -4.92% | -19.83% | -24.73% | 19.14% | -9.64% |
Benchmark Metrics
GlucoTrack Inc has an annualized alpha of 80.25%, beta of 0.33, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 26, 2013.
- This stock participated in 190.38% of S&P 500 Index downside but only -131.34% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.33 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 80.25%
- Beta
- 0.33
- R²
- 0.00
- Upside Capture
- -131.34%
- Downside Capture
- 190.38%
Return for Risk
Risk / Return Rank
GCTK ranks 10 for risk / return — in the bottom 10% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for GlucoTrack Inc (GCTK) and compare them to S&P 500 Index.
| GCTK | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.75 | ||
| Sortino ratioReturn per unit of downside risk | -4.24 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.41 | -0.55 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | 2.93 | -3.89 |
| Martin ratioReturn relative to average drawdown | -1.44 | 13.52 | -14.96 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the GlucoTrack Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the GlucoTrack Inc was 100.00%, occurring on May 21, 2026. The portfolio has not yet recovered.
The current GlucoTrack Inc drawdown is 100.00%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -100.00%May 2026 | 12y 10mo | — | 12y 10moJul 2013 - now |
Drawdown Indicators
| GCTK | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -56.78% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -95.64% | -9.10% | -86.54% |
Max Drawdown (3Y)Largest decline over 3 years | -99.99% | -18.90% | -81.09% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -25.43% | -74.57% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | -33.92% | -66.08% |
Current DrawdownCurrent decline from peak | -100.00% | -0.74% | -99.26% |
Average DrawdownAverage peak-to-trough decline | -78.76% | -10.72% | -68.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.82% | 1.97% | +61.85% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of GlucoTrack Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how GlucoTrack Inc is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with GCTK
Add GlucoTrack Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GCTK